Renaissance Group LLC Amgen Inc Transaction History

Renaissance Group LLC

$2.36 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $3,835 - $4,326	15 Added 1.54%	990 $285,000
Q2 2023 Aug 10, 2023	BUY	$214.27 - $253.37 $20,998 - $24,830	98 Added 11.17%	975 $216,000
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $28,170 - $35,794	-123 Reduced 12.3%	877 $230,000
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $1,614 - $1,797	-7 Reduced 0.7%	1,000 $243,000
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $52,555 - $58,306	-225 Reduced 18.26%	1,007 $245,000
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $601,598 - $701,064	-2,711 Reduced 68.75%	1,232 $307,000
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $51,931 - $61,840	240 Added 6.48%	3,943 $907,000
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $147,125 - $163,615	-627 Reduced 14.48%	3,703 $941,000
Q2 2020 Aug 12, 2020	SELL	$197.81 - $242.74 $78,134 - $95,882	-395 Reduced 8.36%	4,330 $1.02 Million
Q1 2020 May 06, 2020	SELL	$182.24 - $241.7 $178,230 - $236,382	-978 Reduced 17.15%	4,725 $958,000
Q4 2019 Feb 12, 2020	BUY	$189.21 - $243.2 $12,109 - $15,564	64 Added 1.13%	5,703 $1.38 Million
Q3 2019 Oct 31, 2019	SELL	$174.11 - $208.62 $55,541 - $66,549	-319 Reduced 5.35%	5,639 $1.09 Million
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $17,836 - $20,908	107 Added 1.83%	5,958 $1.1 Million
Q1 2019 Apr 30, 2019	SELL	$180.87 - $203.88 $6,873 - $7,747	-38 Reduced 0.65%	5,851 $1.11 Million
Q4 2018 Feb 04, 2019	SELL	$178.4 - $208.25 $16,948 - $19,783	-95 Reduced 1.59%	5,889 $1.15 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $121,179 - $136,614	-654 Reduced 9.85%	5,984 $1.24 Million
Q2 2018 Aug 07, 2018	SELL	$166.05 - $186.51 $55,792 - $62,667	-336 Reduced 4.82%	6,638 $1.23 Million
Q1 2018 Apr 30, 2018	SELL	$169.43 - $198.0 $31.2 Million - $36.5 Million	-184,235 Reduced 96.35%	6,974 $1.19 Million
Q4 2017 Feb 06, 2018	SELL	$168.79 - $188.59 $1.21 Million - $1.35 Million	-7,161 Reduced 3.61%	191,209 $33.3 Million
Q3 2017 Nov 08, 2017	BUY	$167.29 - $191.0 $33.2 Million - $37.9 Million	198,370	198,370 $37 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Group LLC with notifications on news.

Account